In the case of Humira, the medication can be given at home by injection, either in a self-injecting pen or with a syringe. A patient can inject themselves or have a friend or a family member help.

Humira is an injectable medication. People can self-administer it at home, though they may require training to do so. However, some individuals may need to get the injections at their doctor’s ...

Medically reviewed by Shadi Hamdeh, MDMedically reviewed by Shadi Hamdeh, MD Humira (adalimumab) side effects may include pain, irritation, swelling, or itching at the site of the injection ...

In 2006 AbbVie launched the Humira Pen, a self-injecting device, and it is currently in Phase III clinical trials for three additional indications – unspecified arthritis, peripheral ...

They may differ slightly in ingredients or how they’re administered. Humira, for example, is given by self-injection. Whether biosimilars have devices that make them easy for patients to ...

Part B may pay for biological injections administered by a healthcare worker at a hospital or clinic. Like with Humira, if you self-administer the drug, Part D may cover it depending on your ...

Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...